Skip to main content
KOD logo

Kodiak Sciences Inc.

KODNASDAQHealthcareBiotechnology

$99.87
Today:- (-)1Y +595.65%

As of Oct 9, 2026 close

Market cap
$6.25B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.94$104.00
Volume (live)
-
Avg. volume (3M)
2.70M

Kodiak Sciences (KOD) Stock Price & Financial Analysis

Kodiak Sciences Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$93.70 - $100.33
52-Week High$104.00
52-Week Low$10.94
Open$94.97
Volume (last close)1.74M
Average Volume (3M)2.70M
Size & Valuation
Market Cap6.25B
Shares Outstanding62.63M
Price to Book (P/B)96.62
EV/EBITDA-28.29
Technical Indicators
50-Day MA$47.81
200-Day MA$36.97
1-Year Change+595.65%
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Compare KOD with other stocks →

Kodiak Sciences at a Glance

Kodiak Sciences (KOD) has a market capitalization of $6.25B.

It holds $125.90M in cash and securities against $95.70M of debt, a net cash position of $30.20M.

Kodiak Sciences does not currently pay a dividend.

The share price is up 595.6% over the past year. At $99.87 it sits near the top of its 52-week range of $10.94 to $104.00, above its 200-day moving average of $36.97.

Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $115.20, 15.3% above the latest close.

Frequently Asked Questions About Kodiak Sciences

What is the current stock price for KOD?

As of the Oct 9, 2026 close, KOD stock trades at $99.87. The 52-week range is $10.94–$104.00, with a day range of $93.70–$100.33.

What is the P/E ratio for KOD?

The P/E ratio (Price-to-Earnings) for KOD is shown in the Key Statistics section. This valuation metric helps compare Kodiak Sciences Inc. to industry peers.

Does KOD pay dividends?

Kodiak Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KOD?

Based on 9 analysts, the consensus for KOD is Buy.

What is the market cap of KOD?

Kodiak Sciences's market capitalization is $6.25B, classifying it as a mid-cap company. Kodiak Sciences operates in the Healthcare sector within the Biotechnology industry.